Eric Swayze sold $2,031 of IONS
EVP Research at IONIS PHARMACEUTICALS INC. 53 shares at an average of $38.31, traded Oct 16, 2024, filed Oct 17, 2024.
Score components
- +15RoleOfficer
- 0Trade size$2k at market
- +10Share of holdings soldSold 25% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -10.8%, 3m -16.1%, 6m -26.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000874015-24-000229, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 15, 2024 | MOption exercise Common Stockindirect: by Son | +125 | $0.00 | $0 | 210 | Oct 17, 2024 |
| Oct 16, 2024 | SOpen-market sale Common Stockindirect: by Son | -53 | $38.31 | $2,031 | 157 | Oct 17, 2024 |
| Oct 15, 2024 | MOption exercise Restricted Stock Unitderivativeindirect: by Son | -125 | $0.00 | $0 | 426 | Oct 17, 2024 |
Related signals
Other insiders at IONIS PHARMACEUTICALS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 33Weak | IONIS PHARMACEUTICALS INC | C Frank Bennett EVP, Chief Scientific Officer | $6.7M 85,089 shares | -51% | |
| 11Weak | IONIS PHARMACEUTICALS INC | Joseph Baroldi EVP, Chief Business Officer | $531k 6,659 shares | -15% | |
| 40Moderate | IONIS PHARMACEUTICALS INC | C Frank Bennett EVP, Chief Scientific Officer | $7.1M 85,089 shares | -85% | |
| 48Moderate | IONIS PHARMACEUTICALS INC | C Frank Bennett EVP, Chief Scientific Officer | $488k 5,885 shares | -6% | |
| 52Moderate | IONIS PHARMACEUTICALS INC | Joseph Baroldi EVP, Chief Business Officer | $439k 5,296 shares | -10% | |
| 48Moderate | IONIS PHARMACEUTICALS INC | Brian Birchler EVP, Corp and Development Ops | $513k 6,179 shares | -9% | |
| 35Weak | IONIS PHARMACEUTICALS INC | C Frank Bennett EVP, Chief Scientific Officer | $675k 8,977 shares | -9% | |
| 40Moderate | IONIS PHARMACEUTICALS INC | Joseph Baroldi EVP, Chief Business Officer | $610k 8,056 shares | -17% | |
| 40Moderate | IONIS PHARMACEUTICALS INC | Brian Birchler EVP, Corp and Development Ops | $637k 8,480 shares | -12% | |
| 45Moderate | IONIS PHARMACEUTICALS INC | Joseph H Wender director | $2.3M 28,000 shares | -44% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.